Clinicopathological profile of patients underwent gastrectomy for gastric cancer in the Southwest region of Paraná between 2015 and 2020

Authors

DOI:

https://doi.org/10.5433/1679-0367.2024v45n2p211

Keywords:

Medical oncology, Stomach neoplasms, Adenocarcinoma

Abstract

Introduction: gastric cancer is one of the five most common types of cancer. Stomach tumors have a multifactorial etiology. Nonspecific symptomatology in the initial stages favors an advanced condition at the time of diagnosis.
Objective: to characterize the profile of patients diagnosed with stomach cancer who underwent gastrectomy at the Francisco Beltrão Cancer Hospital (CEONC).
Material and Method: this is a descriptive observational study of 76 patients treated at CEONC in Francisco Beltrão, from 2015 to 2020. Patients not submitted to surgical procedure or diagnosed with benign pathologies were excluded.
Results: most gastric tumors were histologically classified as adenocarcinoma (84.21%), and this tumor type was more prevalent in patients over 60 years of age. The rate of advanced tumors that could not be totally resected is high, and surgeries with free margins were 46.88% in adenocarcinomas. Regarding the surgical procedure of choice, total gastrectomy was the surgery performed on most gastric tumors. As for staging using the TNM system, 35.94% of cases were classified as T3 or T4 when it was possible to obtain such information.
Conclusion: gastric cancer is silent in the initial stages, making early diagnosis difficult. The advanced stage of diagnosis limits treatment options, leading to high mortality rates. Therefore, the need for research directed to the subject is evident, in order to understand the epidemiological profile of the region, as a tool for decision-making.

Downloads

Download data is not yet available.

Author Biographies

Ricardo Augusto Tenfen Carneiro, Western Paraná State University

Specialization in General Surgery Residency at theUniversidade Estadual do Oeste do Paraná (Unioste), Francisco Beltrão, Paraná, Brazil. Resident in General Surgery at theUniversidade Estadual do Oeste do Paraná (Unioste), Francisco Beltrão, Paraná.

Geisiane Aparecida Przendziuk, Western Paraná State University

Medical student at the Universidade Estadual do Oeste do Paraná (Unioeste), Francisco Beltrão, Paraná.

Ana Beatriz Flores, Western Paraná State University

Medical student at the Universidade Estadual do Oeste do Paraná (Unioeste), Francisco Beltrão, Paraná.

Wilson da Silva Pereira Junior, Western Paraná State University

Medical student at the Universidade Estadual do Oeste do Paraná (Unioeste), Francisco Beltrão, Paraná.

Janoário Athanázio Oliveira de Souza, Hospital do Câncer de Francisco Beltrão - CEONC

Residência Médica pela Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brasil. Diretor Clínico do Hospital do Câncer de Francisco Beltrão (CEONC), Francisco Beltrão, Paraná

Daniel Rech, Western Paraná State University

Master's Degree in Applied Health Sciences from the Universidade Estadual do Oeste do Paraná (Unioeste), Francisco Beltrão, Paraná, Brazil. Coordinator of the Medicine course at the Universidade Estadual do Oeste do Paraná (Unioeste), Francisco Beltrão, Paraná, Brazil.

Carolina Panis, Western Paraná State University

PhD in Experimental Pathology from the Universidade Estadual de Londrina (UEL), Londrina, Paraná, Brazil. Professor at the Universidade Estadual do Oeste do Paraná (Unioeste), Francisco Beltrão, Paraná.

References

Aranha MFAC, Silva ABD, Souza INTC, Oliveira RCS. Fatores que influenciam a infecção por H. Pylori e a ocorrência de câncer gástrico: uma revisão sistemática. Rev Med (São Paulo) [Internet]. 2023 [citado 2023 ago 8];102(3):e-199415. Disponível em: https://www.revistas.usp.br/revistadc/article/view/199415

Arregi MMU, Férrer DPC, Assis ECV, Paiva FDS, Sobral LBG, André NF, Silva TC. Perfil Clínico-Epidemiológico das Neoplasias de Estômago Atendidas no Hospital do Câncer do Instituto do Câncer do Ceará, no Período 2000-2004. Rev Bras Cancerol [Internet]. 2009 jun 30 [citado 2024 nov. 4];55(2):121-8. Disponível em: https://rbc.inca.gov.br/index.php/revista/article/view/1641

Bickenbach KA, Gonen M, Strong V, Brennan MF, Coit DG. Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol. 2013;20(8):2663-8. doi: 10.1245/s10434-013-2950-5.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492.

Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202-9. doi: 10.1038/nature13480.

Capelario EFS, Silva FRA, Cunha GM, Caetano BRF, Souza BCR, Pedroza AP, et al. Group I carcinogen infection, Helicobacter pylori, as a predisposing factor for Malt Lymphoma. RSD [Internet]. 2022 [cited 2023 Aug 8];11(13):e153111335419. Available from: https://rsdjournal.org/index.php/rsd/article/view/35419

Carvalho TC, Borges AKM, Silva IF. Gastric cancer cases in Brazil and waiting times for diagnosis and treatment. Cien Saude Colet [Internet]. 2023 out [citado 2024 nov 4]. Disponível em: http://cienciaesaudecoletiva.com.br/artigos/gastric-cancer-cases-in-brazil-and-waiting-times-for-diagnosis-and-treatment/18949?id=18949

Chen YC, Fang WL, Wang RF, Liu CA, Yang MH, Lo SS, et al. Clinicopathological Variation of Lauren Classification in Gastric Cancer. Pathol Oncol Res. 2016;22(1):197-202. doi: 10.1007/s12253-015-9996-6.

Costa LB da, Toneto MG, Moreira LF. Do proximal and distal gastric tumours behave differently? Arq Bras Cir Dig [Internet] 2016 [cited 2023 Aug 10];29(4):232-5. Available from: https://www.scielo.br/j/abcd/a/yHk63sWvTvf5fstvZR4hPRQ/?lang=pt

Costa P, Leite R de CB de O. Estratégias de Enfrentamento Utilizadas pelos Pacientes Oncológicos Submetidos a Cirurgias Mutiladoras. Rev Bras Cancerol [Internet] 2009 [citado 2023 ago 12];55(4):355-64. Disponível em: https://rbc.inca.gov.br/index.php/revista/article/view/1591

Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354-62. doi: 10.3748/wjg.v12.i3.354.

De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15. doi: 10.1016/S1470-2045(12)70137-7.

Digklia A, Wagner AD. Advanced gastric cancer: Current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403-14. doi: 10.3748/wjg.v22.i8.2403.

Henriques AC, Waisberg J, Godinho CA, Bagarollo C, Arita JH, Pires SP, et al. Recidiva local de adenocarcinoma gástrico após gastrectomia total: a propósito de um caso com recidiva tardia e revisão da literatura. Arq Med ABC [Internet] 2006 [citado 2023 ago 10];31(2):83-6. Disponível em: https://nepas.emnuvens.com.br/amabc/article/view/258

Ilias EJ, Malheiros CA, Kassab P, Castro OAP. Linfadenectomia no adenocarcinoma gástrico. Rev Assoc Med Bras [Internet]. 2006 [citado 2023 ago 8];52(4)):270-2. Disponível em: https://www.scielo.br/j/ramb/a/6HmXTchLmFTGqLMk9y7rWXj/?lang=pt

Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1-25. doi: 10.1007/s10120-022-01331-8.

Laurentino RN, Ribeiro AN, Santos MKAA, Leoni DR, Vimercati JO, Lorencini VS, et al. Perfil epidemiológico da neoplasia malígna de estômago no Brasil entre 2017 a 2022. Braz J Implantol Health Sci. 2023;5(5):6461-7. doi: 10.36557/2674-8169.2023v5n5p6461-6471

Lyons K, Le LC, Pham YT, Borron C, Park JY, Tran CTD, et al. Gastric cancer: epidemiology, biology, and prevention: a mini review. Eur J Cancer Prev. 2019;28(5):397-412. doi: 10.1097/CEJ.0000000000000480.

McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014;11(11):664-74. doi: 10.1038/nrgastro.2014.143.

MinisteÌrio da SauÌde (BR). Instituto Nacional do CaÌ‚ncer JoseÌ Alencar Gomes da Silva. Estimativa 2018: incideÌ‚ncia de caÌ‚ncer no Brasil. Rio de Janeiro (RJ): INCA; 2018.

Ministério da Saúde (BR). Neoplasia maligna do estômago (taxas ajustadas). Brasília (DF): Ministério da Saúde; 2022.

Montoya M, Gómez R, Ahumada F, Martelo A, Toro J, Pérez E, et al. Caracterización de 130 pacientes sometidos a gastrectomía por cáncer gástrico en el Instituto de Cancerología-Clínica Las Américas de Medellín. Rev Colomb Cancerol [Internet] 2016 [citado 2023 ago 6];20(2):73-8. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-90152016000200004

Morais BCF, Resende BT, Lopes CEZ, Diniz MFL, Hollunder RG, Pujatti PB, et al. Perfil sócio demográfico e clínico de pacientes com Câncer Gástrico atendidos em um hospital de referência no interior de Minas Gerais. Rev Med Minas Gerais. 2022;30(suppl 4). doi: 10.5935/2238-3182.v30supl.4.02.

Morais CF de, Wiggers WJ, Neto AC. Análise de aspectos epidemiológicos e histopatológicos de 95 pacientes com neoplasia gástrica maligna no oeste do paraná: analogia com a literatura brasileira e mundial. Thêma Sci [Internet]. 2016 [citado 2023 ago 6];6(2E). Disponível em: https://themaetscientia.fag.edu.br/index.php/RTES/article/view/728

Napoleão Júnior OA, Alexandre ATV, Barboza DRMM, Meireles MS, Pinheiro MV, Pinheiro ATM. Perfil epidemiológico e histopatológico do câncer gástrico. Cadernos ESP [Internet]. 2019 [citado 2023 ago 6];5(2):26-33. Disponível em: https://cadernos.esp.ce.gov.br/index.php/cadernos/article/view/60

Oliveros R, Navarrera LF. Diagnóstico, estadificación y tratamiento del cáncer gástrico en Colombia desde 2004 a 2008 (REGATE - Colombia). Rev Col Gastroenterol [Internet]. 2012;27(4):269-74. Disponible en: https://www.redalyc.org/articulo.oa?id=337731607003.

Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, et al. Treatment of gastric cancer. World J Gastroenterol. 2014;20(7):1635-49. doi: 10.3748/wjg.v20.i7.1635.

Papachristou DN, Fortner JG. Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol. 1981;18(1):47-53. doi: 10.1002/jso.2930180108.

Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7(32):52307-16. doi: 10.18632/oncotarget.10740.

Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer. 2000;89(2):255-61. doi: 10.1002/1097-0142(20000715)89:2<255::aid-cncr8>3.0.co;2-n.

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239-48. doi: 10.2147/CMAR.S149619.

Slavin TP, Weitzel JN, Neuhausen SL, Schrader KA, Oliveira C, Karam R. Genetics of gastric cancer: what do we know about the genetic risks? Transl Gastroenterol Hepatol. 2019;4:55. doi: 10.21037/tgh.2019.07.02.

Souza ARL. Gastrectomia subtotal e total com linfadenectomia D2: perfil epidemiológico, anatomopatológico e clínico de pacientes gastrectomizados por adenocarcinoma de estômago. [dissertação] Passo Fundo (RS): Universidade Federal da Fronteira Sul; 2018.

Souza, LA. Epidemiologia do câncer de estômago [dissertação]. Ribeirão Preto (SP): Universidade de São Paulo; 2022.

Springer SRAS, Guedes MTS, Silva Junior OC, Carreiro MA, Silva A. Perfil del paciente con cáncer gástrico del Instituto Nacional del Cáncer. Enferm Glob [Internet]. 2020 [citado 2024 nov 8];19(58):21-67. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1695-61412020000200002&lng=es.

Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060):2654-64. doi: 10.1016/S0140-6736(16)30354-3.

Venturelli M. Francisco. Margen positivo (R1) en la biopsia intraoperatoria durante una gastrectomía total por cáncer gástrico. Rev Cir [Internet]. 2020 jun [citado 2023 ago 12];72(3):257-61. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S2452-45492020000300257&lng=es

Woo JW, Ryu KW, Park JY, Eom BW, Kim MJ, Yoon HM, et al. Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection. World J Surg. 2014;38(2):439-46. doi: 10.1007/s00268-013-2301-5. Erratum in: World J Surg. 2014 Jul;38(7):1868.

Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12(1):17-20. doi: 10.3748/wjg.v12.i1.17.

Zilberstein B, Mucerino DR, Yagi OK, Ribeiro-Junior U, Lopasso FP, Bresciani C, et al. Resultados da gastrectomia D2 para o câncer gástrico: dissecção da cadeia linfática ou ressecção linfonodal múltipla? ABCD, Arq Bras Cir Dig [Internet] 2012 [citado 2023 ago 6];25:161-4. Disponível em: https://www.scielo.br/j/abcd/a/Gtv3NxH6rq87FnHZCHPLNrR/?lang=pt

Published

2024-12-27

How to Cite

1.
Carneiro RAT, Przendziuk GA, Flores AB, Pereira Junior W da S, Souza JAO de, Rech D, et al. Clinicopathological profile of patients underwent gastrectomy for gastric cancer in the Southwest region of Paraná between 2015 and 2020. Semin. Cienc. Biol. Saude [Internet]. 2024 Dec. 27 [cited 2025 Dec. 23];45(2):211-24. Available from: https://ojs.uel.br/revistas/uel/index.php/seminabio/article/view/50242

Issue

Section

Artigos